Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Resveratrol, a polyphenolic compound found in grapes and some berries, has been studied for its potential cardiovascular benefits, including effects on lipid metabolism. "Resveratrol conjugates" refers to various metabolites and derivatives of resveratrol, which are the forms commonly found in human plasma after supplementation. Some preclinical studies (in vitro and animal models) suggest resveratrol and its metabolites may exert lipid-lowering effects by influencing pathways involved in lipid metabolism, such as reducing hepatic triglyceride synthesis and enhancing fatty acid oxidation. A few small clinical trials in humans have examined the impact of resveratrol supplementation on triglyceride levels, with mixed results. Some studies report modest reductions in triglycerides, particularly in populations with metabolic syndrome or type 2 diabetes, while others find no significant effect. Systematic reviews and meta-analyses generally conclude that resveratrol may have a small, possibly clinically insignificant effect on triglyceride levels, and that data are inconsistent and limited by study heterogeneity and small sample sizes. There is no robust, high-quality evidence supporting a strong triglyceride-lowering effect of resveratrol or its conjugates. Thus, while there is some scientific investigation, the evidence for using resveratrol conjugates to treat or support high triglycerides is weak and not currently endorsed by clinical guidelines.

More about Resveratrol conjugates (mixed)
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by Resveratrol conjugates (mixed)

Products containing Resveratrol conjugates (mixed)